X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ABBOTT INDIA DR. DATSONS LABS/
ABBOTT INDIA
 
P/E (TTM) x -10.9 37.1 - View Chart
P/BV x 0.2 9.5 1.7% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DR. DATSONS LABS   ABBOTT INDIA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ABBOTT INDIA
Mar-18
DR. DATSONS LABS/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1266,110 2.1%   
Low Rs313,996 0.8%   
Sales per share (Unadj.) Rs133.01,552.2 8.6%  
Earnings per share (Unadj.) Rs0.2188.8 0.1%  
Cash flow per share (Unadj.) Rs6.6196.4 3.4%  
Dividends per share (Unadj.) Rs055.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs128.8796.6 16.2%  
Shares outstanding (eoy) m31.6621.25 149.0%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.3 18.1%   
Avg P/E ratio x516.126.8 1,928.5%  
P/CF ratio (eoy) x11.825.7 46.0%  
Price / Book Value ratio x0.66.3 9.6%  
Dividend payout %029.1 0.0%   
Avg Mkt Cap Rs m2,477107,376 2.3%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m563,937 1.4%   
Avg. sales/employee Rs ThNM9,929.3-  
Avg. wages/employee Rs ThNM1,185.1-  
Avg. net profit/employee Rs ThNM1,207.7-  
INCOME DATA
Net Sales Rs m4,21132,985 12.8%  
Other income Rs m791,170 6.7%   
Total revenues Rs m4,28934,155 12.6%   
Gross profit Rs m5695,245 10.8%  
Depreciation Rs m204162 126.3%   
Interest Rs m43038 1,126.2%   
Profit before tax Rs m136,215 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62,203 0.3%   
Profit after tax Rs m54,012 0.1%  
Gross profit margin %13.515.9 84.9%  
Effective tax rate %48.035.4 135.5%   
Net profit margin %0.112.2 0.9%  
BALANCE SHEET DATA
Current assets Rs m6,85222,655 30.2%   
Current liabilities Rs m6,7116,681 100.4%   
Net working cap to sales %3.348.4 6.9%  
Current ratio x1.03.4 30.1%  
Inventory Days Days16165 248.3%  
Debtors Days Days31829 1,092.5%  
Net fixed assets Rs m3,673835 439.6%   
Share capital Rs m317213 149.0%   
"Free" reserves Rs m3,76116,715 22.5%   
Net worth Rs m4,07816,928 24.1%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63324,162 52.3%  
Interest coverage x1.0163.7 0.6%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.4 24.4%   
Return on assets %3.416.8 20.5%  
Return on equity %0.123.7 0.5%  
Return on capital %7.736.9 20.8%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m964369 261.6%   
Fx outflow Rs m6073,807 15.9%   
Net fx Rs m357-3,438 -10.4%   
CASH FLOW
From Operations Rs m1,3451,527 88.1%  
From Investments Rs m-2,256-2,148 105.0%  
From Financial Activity Rs m-1,200-1,024 117.1%  
Net Cashflow Rs m-2,111-1,646 128.3%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 1.4 0.1 1,350.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.1 550.3%  
Shareholders   20,807 18,270 113.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES PHARMA SCIENCE  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Finish Flat; IT and Pharma Stocks Witness Selling(Closing)

Share markets in India ended their trading session on a flattish note. Sectoral indices ended on a mixed note with stocks in the IT sector and pharma sector witnessing most of the selling pressure.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS